Glanbia plc
GL9
Classifica tra le azioni
#3196
Operating globally as a prominent nutrition company, Glanbia plc specializes in... Operating globally as a prominent nutrition company, Glanbia plc specializes in the development and distribution of sports and lifestyle nutrition products. These offerings come in various forms, including powdered supplements, ready-to-eat bars, convenient snacking foods, and prepared beverages. The company reaches consumers through a wide array of distribution channels, encompassing specialty retailers, online platforms, fitness centers, and larger retail environments such as food, drug, mass-market, and club stores. Additionally, Glanbia is a key producer of cheese, a diverse range of dairy and non-dairy nutritional and functional ingredients, and vital vitamin and mineral premixes. Its operational scope extends beyond product manufacturing to include activities such as financing, research and development, property management, receivables handling, general business administration, property leasing, various business services, and weight management solutions. The company boasts a robust portfolio of renowned brands, including OPTIMUM NUTRITION, SlimFast, BSN, ISOPURE, NUTRAMINO, think!, Amazing Grass, and BODY&FIT. Glanbia plc was founded in 1964 and maintains its corporate headquarters in Kilkenny, Ireland.
Prezzo delle azioni
$22.80
Capitalizzazione di mercato
$5.51B
Variazione (1 giorno)
-0.98%
Variazione (1 anno)
31.93%
Paese
IE
Scambia Glanbia plc (GL9)
Categoria
Consumer Defensive
Utile per Glanbia plc (GL9)
Utile nel 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Glanbia plc, gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, uguale a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Storico degli utili di Glanbia plc dal 2001 al 2026
Utile alla fine di ogni anno
| Anno | Utile | Cambia |
|---|---|---|
| 2025 | $217.73M | 1.09% |
| 2024 | $215.38M | -44.90% |
| 2023 | $390.89M | 61.74% |
| 2022 | $241.67M | 34.51% |
| 2021 | $179.67M | 12.53% |
| 2020 | $159.66M | -28.53% |
| 2019 | $223.39M | -27.14% |
| 2018 | $306.59M | 11.24% |
| 2017 | $275.62M | 16.58% |
| 2016 | $236.43M | -0.44% |
| 2015 | $237.46M | 13.07% |
| 2014 | $210.02M | -13.23% |
| 2013 | $242.04M | 22.16% |
| 2012 | $198.12M | 44.96% |
| 2011 | $136.67M | -24.12% |
| 2010 | $180.12M | -12.18% |
| 2009 | $205.09M | 41.00% |
| 2008 | $145.45M | 24.74% |
| 2007 | $116.60M | 35.58% |
| 2006 | $86.00M | 12.04% |
| 2005 | $76.76M | -46.99% |
| 2004 | $144.81M | -872.54% |
| 2003 | $-18.74M | 120.20% |
| 2002 | $-8.51M | -117.62% |
| 2001 | $48.30M | 0.00% |
Utile per aziende simili o concorrenti
| Azienda | Utile | Differenza negli utili | Il paese |
|---|---|---|---|
| $12.96B | - |
CH
|
|
| - | - |
FR
|
|
| - | - |
JP
|
|
| - | - |
BR
|
|
| $-3.66B | - |
US
|
